Yunju Jeong

ORCID: 0000-0002-0453-3475
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gut microbiota and health
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Pharmacological Effects of Natural Compounds
  • Clostridium difficile and Clostridium perfringens research
  • PI3K/AKT/mTOR signaling in cancer
  • Immune Cell Function and Interaction
  • Mycobacterium research and diagnosis
  • Immune Response and Inflammation
  • Autoimmune and Inflammatory Disorders Research
  • Liver physiology and pathology
  • NF-κB Signaling Pathways
  • Helicobacter pylori-related gastroenterology studies
  • Microbial Metabolites in Food Biotechnology
  • Hydrogen's biological and therapeutic effects
  • Ginseng Biological Effects and Applications
  • Advancements in Transdermal Drug Delivery
  • Glycosylation and Glycoproteins Research
  • Immune cells in cancer
  • Drug-Induced Hepatotoxicity and Protection
  • Probiotics and Fermented Foods
  • Food Quality and Safety Studies
  • Inflammasome and immune disorders
  • Eosinophilic Disorders and Syndromes
  • Antimicrobial Peptides and Activities
  • Single-cell and spatial transcriptomics

Catholic University of Korea
2020-2025

Harvard University
2020-2024

Brigham and Women's Hospital
2020-2024

Kyung Hee University
2024

Food & Nutrition
2024

Yonsei University
2021-2023

Pulmonary and Critical Care Associates
2023

Seoul National University
2011-2022

Daegu Haany University
2021-2022

Namseoul University
2020

Pro-inflammatory fibroblasts are critical for pathogenesis in rheumatoid arthritis, inflammatory bowel disease, interstitial lung and Sjögren's syndrome represent a novel therapeutic target chronic disease. However, the heterogeneity of fibroblast phenotypes, exacerbated by lack common cross-tissue taxonomy, has limited our understanding which pathways shared multiple diseases.

10.1016/j.medj.2022.05.002 article EN cc-by Med 2022-05-31

Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation of the joints and extra-articular manifestations. Recent studies have shown that microorganisms affect RA pathogenesis. However, few examined microbial distribution early patients, particularly female patients. In present study, we investigated gut microbiome profile functions in including preclinical clinically apparent cases. Changes microbiological diversity, composition, function each group were...

10.3390/jcm8050693 article EN Journal of Clinical Medicine 2019-05-16

Faecalibacterium prausnitzii is a major commensal bacterium in the human gut. It produces short-chain fatty acids that promote intestinal health. However, extremely oxygen-sensitive, making it difficult to develop as probiotic. To facilitate practical application of F. prausnitzii, we investigated factors affect its growth and mammalian gut colonization. We evaluated cross-feeding interactions between seven Bifidobacterium strains, anti-inflammatory properties bacterial metabolites produced...

10.3390/microorganisms8050788 article EN cc-by Microorganisms 2020-05-25

Macrophages regulate protective immune responses to infectious microbes, but aberrant macrophage activation frequently drives pathological inflammation. To identify regulators of vigorous activation, we analyzed RNA-seq data from synovial macrophages and identified SLAMF7 as a receptor associated with superactivated state in rheumatoid arthritis. We implicated IFN-γ key regulator expression engaging drove strong wave inflammatory cytokine expression. Induction TNF-α after engagement...

10.1126/sciimmunol.abf2846 article EN Science Immunology 2022-02-11
Ana B. Villaseñor-Altamirano Dhawal Jain Yunju Jeong Jaivardhan A. Menon Mari Kamiya and 95 more Hibah Haider Reshmi Manandhar Muhammad Dawood Amir Sheikh Humra Athar Louis T. Merriam Min Hyung Ryu Takanori Sasaki Peter J. Castaldi Deepak A. Rao Lynette M. Sholl Marina Vivero Craig P. Hersh Xiaobo Zhou Justus Veerkamp Jeong H. Yun Edy Y. Kim Markus Koch Alessandro Arduini Hana Černecká Nicole Schmidt Alexis Laux‐Biehlmann Damian Brockschnieder Xiaofei Cong Anna Engler Mahmoud M. Ibrahim Dhawal Jain Ivan Kryukov Kuldeep Kumawat T. Lang Yelena Leathurby Xin Lin Joerg Meding Carlos Neideck Kseniya Obraztsova Chandan Pavuluri Magdalena Platzk Patrick Smith Florian Sohler Salil Srivastava Pooja Srinivasa Tobias Strunz Jody Sylvia Lea Vaas Justus Veerkamp Alex Zink Lingyao Zhang Liang Zeng Xin Lin Edwin K. Silverman Vincent J. Carey Peter J. Castaldi Michael H. Cho Dawn L. DeMeo Craig P. Hersh Brian D. Hobbs Matthew Moll Heena Rijhwani Jeong H. Yun Xiaobo Zhou Bruce D. Levy Yohannes Tesfaigzi Humra Athar Yan Bai Rebecca M. Baron Tracy J. Doyle Souheil El‐Chemaly Laura E. Fredenburgh Gary Matt Hunninghake Yunju Jeong Edy Y. Kim Nandini Krishnamoorthy Yohannes A. Mebratu Mark A. Perrella Joselyn Rojas Quintero Z.H. Negasi Mohammed Mizanur Rahman D. Tassew Nirmal S. Sharma Tomoyoshi Tamura Ana B. Villaseñor-Altamirano Benjamin D. Medoff Elizabeth Abe Katherine Black Corey Hardin Rachel S. Knipe Barry S. Shea Jill Spiney Mahaa Albsuharif Francesca Giacona Armin Jayaswai Greg Keras Sool Lee Jianyuan Liu Chandan Pavuluri Betty Pham

Rationale: Despite the importance of inflammation in chronic obstructive pulmonary disease (COPD), immune cell landscape lung tissue patients with mild-moderate has not been well characterized at single-cell and molecular level. Objectives: To define from COPD resolution. Methods: We performed transcriptomic, proteomic, T-cell receptor repertoire analyses on (n = 5, Global Initiative for Chronic Obstructive Lung Disease I or II), emphysema without airflow obstruction 5), end-stage 2),...

10.1164/rccm.202305-0924oc article EN American Journal of Respiratory and Critical Care Medicine 2023-09-27

Abstract Background Rheumatoid arthritis (RA) is a systemic chronic inflammatory disease that leads to joint destruction and functional disability due the targeting of self-antigens present in synovium, cartilage, bone. RA caused by number complex factors, including genetics, environment, dietary habits, altered intestinal microbial flora. Microorganisms gut bind nod-like receptors Toll-like regulate immune system produce various metabolites, such as short-chain fatty acids (SCFAs) interact...

10.1186/s13075-023-03118-3 article EN cc-by Arthritis Research & Therapy 2023-07-26

Lactic acid bacteria (LAB) are known to have a significant ability colonize the human intestinal tract and adhere surface of epithelial cells. Among various lactic bacteria, exopolysaccharide (EPS) producing strains provide variety health benefits for their hosts (e.g. anti-inflammatory, antioxidant, antitumor stress tolerant effects). Recently, EPSs EPS-producing cultures gained interest within food industry playing important roles as biothickeners texturizing agents due hydrocolloidal...

10.1186/s12934-019-1158-1 article EN cc-by Microbial Cell Factories 2019-06-13

We examined the effect of combination therapy with metformin and tacrolimus on immune parameters including T regulatory (Treg) type 17 helper (Th17) cells in vitro vivo mice liver transplantation (LT) patients. cell proliferation subtypes after activation or allogeneic stimulation were evaluated. RNA sequencing microarray analysis used to evaluate differences gene expression. Metformin administered graft-versus-host disease (GVHD) effects assessed. Five LT patients treated changes Treg Th17...

10.3389/fimmu.2020.581728 article EN cc-by Frontiers in Immunology 2021-01-08

Abstract Background Rapamycin, an inhibitor of the serine/threonine protein kinase mTOR, is immunosuppressant used to treat renal transplant recipients, but it can cause endothelial and mitochondrial dysfunction. Metformin for treatment type 2 diabetes was reported exert therapeutic effects against rheumatoid arthritis obesity by improving dysfunction via activation fibroblast growth factor 21. We investigated rapamycin–metformin combination therapy in obese mice with collagen-induced (CIA)....

10.1186/s13075-020-02174-3 article EN cc-by Arthritis Research & Therapy 2020-04-10

The potential therapeutic effects of probiotic bacteria in rheumatoid arthritis (RA) remain controversial. Thus, this study aimed to discover based on the relationship between gut microbiome and factor (RF) RA. Bacterial genomic DNA was extracted from fecal samples 93 RA patients 16 healthy subjects. Microbiota profiling conducted through 16S rRNA sequencing bioinformatics analyses. Bifidobacterium strains human peripheral blood mononuclear cells collagen-induced (CIA) mice were assessed....

10.3389/fimmu.2021.736196 article EN cc-by Frontiers in Immunology 2021-11-15

Butyl-fructooligosaccharides (B-FOSs) are newly synthesized prebiotics composed of short-chain FOS (GF2, 1-kestose; GF3, nystose; GF4, fructofuranosyl-nystose; GF5, 1-F-(1-b-D-fructofuranosyl)-2-nystose) bound with one or two butyric groups by ester bonds. Previous in vitro studies have shown that B-FOS treatment increases butyrate production and protects the growth butyrate-producing bacteria during fermentation. The aim this study was to further test as a novel prebiotic compound...

10.1039/d1fo03337a article EN Food & Function 2022-01-01

The Met receptor tyrosine kinase is an attractive target for cancer therapy as it promotes invasive tumor growth. SAIT301 a novel anti-Met antibody, which induces LRIG1-mediated degradation and inhibits However, detailed downstream mechanism by LRIG1 mediates protein down-regulation unknown. In the present study, we discovered that ubiquitination of LRIG1, in turn recruitment complex to lysosome through its interaction with Hrs, resulting concomitant both Met. We also identified USP8...

10.1038/srep04980 article EN cc-by-nc-sa Scientific Reports 2014-05-15

Abstract Background To evaluate the immunomodulatory effect of Lactobacillus sakei in a mouse model rheumatoid arthritis (RA) and human immune cells. Methods We evaluated whether L. reduced severity collagen-induced (CIA) modulated interleukin (IL)-17 IL-10 levels, as well it affected differentiation CD4 + T cells regulatory B osteoclastogenesis after culturing bone marrow-derived mononuclear with sakei. Results The helper 17 serum level IL-17 were suppressed by both peripheral blood...

10.1186/s12967-020-02477-8 article EN cc-by Journal of Translational Medicine 2020-08-15

Short-chain fatty acids (SCFAs), especially butyrate, produced in mammalian intestinal tracts via fermentation of dietary fiber, are known biofunctional compounds humans. However, the variability fermentable fiber consumed on a daily basis and diversity gut microbiota within individuals often limits production short-chain human gut. In this study, we attempted to enhance butyrate levels fecal samples by utilizing butyl-fructooligosaccharides (B-FOS) as novel prebiotic substance. Two major...

10.3390/ijms21020445 article EN International Journal of Molecular Sciences 2020-01-10

Although interstitial lung disease (ILD) causes significant morbidity and mortality in rheumatoid arthritis (RA), it is difficult to predict the development or progression of ILD, emphasising need for improved discovery through minimally invasive diagnostic tests. Aptamer-based proteomic profiling was used assess 1321 proteins from 159 patients with (RA-ILD), RA without idiopathic pulmonary fibrosis healthy controls. Differential expression gene set enrichment analyses revealed molecular...

10.1136/thorax-2021-217822 article EN Thorax 2022-07-30

c-Met, the high affinity receptor for hepatocyte growth factor (HGF), is one of most frequently activated tyrosine kinases in many human cancers and a target cancer therapy. However, inhibitory targeting c-Met with antibodies has proven difficult, because have intrinsic agonist activity. Therefore, strategy reducing agonism critical successful development therapies based on anti-c-Met antibodies. Here we developed mechanism-based assay method rapid screening antibodies, involving...

10.1007/s10059-012-0194-z article EN cc-by-nc-sa Molecules and Cells 2012-11-23

Patients with RA commonly use gastrointestinal (GI) protective drugs for treatment and prevention of drug-associated GI injuries. However, how these affect the gut microbiota in patients remains unknown. The objective this study was to examine according such as proton pump inhibitors (PPIs), histamine 2-receptor antagonists rebamipide.Faecal samples were obtained from 15 healthy controls 32 who receiving PPI, antagonist or rebamipide. Bacterial DNA extracted faecal 16S rRNA sequencing...

10.1093/rheumatology/keaa316 article EN Lara D. Veeken 2020-05-12

Recently, non-electrolyzed HOCl water has gained the attention of researchers as a new disinfecting agent owing to its high sterilization power, easy accessibility, and safety. Non-electrolyzed was developed through mixing at specific ratio based on hypochlorite mineral supplements, which revealed oxidizing power. In this study, we investigated effects Helicobacter pylori (H. pylori) infection in C57BL/6 mice over 10 weeks. Mice were divided into three groups: normal control (NC) group...

10.3390/pr11051474 article EN Processes 2023-05-12

Fibrosis drives end-organ damage in many diseases. However, clinical trials targeting individual upstream activators of fibroblasts, such as TGFβ, have largely failed. Here, we target the leukemia inhibitory factor receptor (LIFR) a "master amplifier" multiple lung fibroblasts. In idiopathic pulmonary fibrosis (IPF), most common fibrotic disease, found that myofibroblasts had high LIF expression. Further, TGFβ1, one key drivers fibrosis, upregulated expression IPF vitro anti-LIFR antibody...

10.1101/2024.05.21.595153 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2024-05-23

Fibrosis drives end-organ damage in many diseases. However, clinical trials targeting individual upstream activators of fibroblasts, such as TGFβ, have largely failed. Here, we target the leukemia inhibitory factor receptor (LIFR) an “autocrine master amplifier” multiple lung fibroblasts. In idiopathic pulmonary fibrosis (IPF), most common fibrotic disease, found that myofibroblasts had high LIF expression, and fibroblasts fibroblastic foci coexpressed LIFR. IPF, are “leading edge” a key...

10.1073/pnas.2401899121 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2024-12-05
Coming Soon ...